by Kazeem Olalekan A safety alert has come to our attention via the MHRA: Following a review by the Commission on Human Medicines (CHM), the marketing authorisation (licence) for levothyroxine 100 microgram tablets manufactured by Teva has been suspended. Teva levothyroxine 100 microgram tablets will cease to be available in the UK within the next […]
by Kazeem Olalekan MRPharmS Can you spot the difference between these two tablet boxes. They look remarkably similar to me. Admittedly TEVA has done great work to make tablet boxes easily identifiable: An oversight perhaps? Patients beware.